About RMBIO
RMBIO is a company based in Missoula (United States) founded in 2004. RMBIO has raised $2.01 million across 2 funding rounds. RMBIO offers products and services including Fetalgro EX®, Basic Fibroblast Growth Factor bFGF, and Fetal Bovine Serum (FBS). RMBIO operates in a competitive market with competitors including PrognomiQ, BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology and Polyplus Transfection, among others.
- Total Equity Funding$2.01M (USD)
in 2 rounds
- Latest Funding Round$1.11M (USD), Series A
Jun 2015
Products & Services of RMBIO
RMBIO offers a comprehensive portfolio of products and services, including Fetalgro EX®, Basic Fibroblast Growth Factor bFGF, and Fetal Bovine Serum (FBS).
Premium replacement for FBS in cell culture applications
Essential supplement for cell growth and research
USDA-approved serum for consistent laboratory use
Funding Insights of RMBIO
RMBIO has successfully raised a total of $2.01M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.11 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.01M
- Total Rounds 2
- Last Round Series A — $1.11M
- First Round $896,551
(Feb 2011)
All 2 funding rounds of RMBIO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | $1.11M | Series A | – | – | – |
| Feb 2011 | $896,551 | Seed | – | – | – |
People of RMBIO
2 people are tracked at RMBIO (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Martin Horn | Director, Board Member | Leadership |
Annie Roberts | Manager | Team |
Complete people profiles for RMBIO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RMBIO
3 dated milestones of RMBIO across 11 years, from founding to its latest funding, stage changes and deals.
- Founded RMBIO is founded.
- Funding First funding round of $897K.
- Funding Latest funding round, Series A, of $1.1M.
Competitors of RMBIO
RMBIO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology and Polyplus Transfection, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| duoningbio.com | 2005 | Shanghai, China | $14.88M | – | Serum-free cell culture media is supplied to biopharmaceutical industries. | |
| polyplus-transfection.com | 2001 | Illkirch Graffenstaden, France | $3.23M | – | Transfection Solutions for Healthcare and Life Sciences organizations | |
| arunabio.com | 2017 | Athens, United States | $38.51M | – | Neural exosome platform is developed for neurodegenerative disease therapeutics. | |
| biotangents.co.uk | 2015 | Edinburgh, United Kingdom | $5.62M | 13 | Veterinary diagnostics products are developed for bovine viral diarrhea testing. | |
| preomics.com | 2014 | Munich, Germany | $19.14M | 22 | Reagents and instruments for proteomics research are supplied by PreOmics. | |
| fabricnano.com | 2018 | London, United Kingdom | $22.6M | 12 | DNA-based flow reactors are developed for biochemical production. | |
| vivostat.com | 2001 | Alleroed, Denmark | $12.89M | 9 | On-site fibrin sealant preparation systems are developed and provided. |
Detailed competitors of RMBIO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RMBIO
The website of RMBIO (rmbio.com) receives about 4.2K visits a month.
- Monthly visits4.2K
▲ 12.7% vs previous month
Websites whose visitors overlap most with RMBIO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lampire.com | 100% | – | #2,833,014 | View details | |
| bioind.com | 78% | – | – | View details |
Latest news on Rmbio
Complete news archive for RMBIO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to RMBIO
10 companies that operate in the same segment as RMBIO (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RMBIO
RMBIO was founded in 2004 and raised its 1st funding round 7 years after it was founded.
RMBIO is headquartered in Missoula, United States. It is registered at Missoula, Montana, United States.
RMBIO is a funded company, having raised a total of $2.01M across 2 funding rounds to date. The company's 1st funding round was a Seed of $896.55K, raised on Feb 2011.
Rocky Mountain Biologicals was founded in 2004 and is based in Missoula, United States. Operations focus on the life sciences sector, where high-performance sera, protein fractions, and cell culture media are developed and produced. Fully automated processes that are validated and compliant with GMP standards are employed to support cell culture needs.
RMBIO's top competitors include PrognomiQ, FabricNano and RoosterBio.
RMBIO offers Fetalgro EX®, Basic Fibroblast Growth Factor bFGF, and Fetal Bovine Serum (FBS).
RMBIO operates through Rocky Mountain Biologicals, Llc.